A carregar...

The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer

Activating RAS mutations are common in human tumors. These mutations are often markers for resistance to therapy and subsequent poor prognosis. So far, targeting the RAF-MEK-ERK and PI3K-AKT signaling pathways downstream of RAS is the only promising approach in the treatment of cancer patients harbo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Pharmacol Sin
Main Authors: Guin, Sunny, Theodorescu, Dan
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349922/
https://ncbi.nlm.nih.gov/pubmed/25557115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2014.129
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!